论文部分内容阅读
作者报道日本成人白血病协作组230例急性髓细胞白血病(AML)中有40例(17％)AML伴有三系病态造血(TMDS)(根据Brito-Babapulle标准,1987年)。男20例,女20例,中数年龄48.5岁,按FAB分型TMDS的发病率为M_1型5/42例(12％)。M_1型17/80例(21％),M_4型16/57例(34%),M_6型2/6例(33%)。 起病时TMDS-AML的中位血小板数(77.0×10~6/L)显著高于无三系病态造血(NTMDS)AML
The authors reported that 40 (17%) of AML patients with acute myeloid leukemia (AML) in the Japanese adult leukemia collaborative group had AML with tertiary lineage morbid hematopoietic (TMDS) (according to Brito-Babapulle criteria, 1987). There were 20 males and 20 females, the median age was 48.5 years. According to the FAB classification, the incidence of TMDS was 5/42 (12%) of M_1 type. 17/80 cases (21%) of M_1 type, 16/57 cases (34%) of M_4 type and 2/6 cases (33%) of M_6 type. The median number of platelets (77.0 × 10 ~ 6 / L) of TMDS-AML at onset was significantly higher than that of NTMDS without AML